Select Publications
Journal articles
2022, 'Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality Results from a Randomized Controlled Trial of ACE Inhibitors', Clinical Journal of the American Society of Nephrology, 17, pp. 1139 - 1149, http://dx.doi.org/10.2215/CJN.00180122
,2022, 'Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE', International Journal of Cardiology, 358, pp. 103 - 109, http://dx.doi.org/10.1016/j.ijcard.2022.04.044
,2022, 'Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target', International Journal of Stroke, 17, pp. 566 - 575, http://dx.doi.org/10.1177/17474930211025436
,2022, 'The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports', Journal of Hypertension, 40, pp. 847 - 852, http://dx.doi.org/10.1097/HJH.0000000000003107
,2022, 'Blood pressure meta-analysis highlights an implementation gap – Authors’ reply', The Lancet, 399, pp. 1380 - 1380, http://dx.doi.org/10.1016/S0140-6736(22)00114-3
,2022, 'Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study', Stroke, 29, pp. 779 - 787, http://dx.doi.org/10.1161/STROKEAHA.121.034580
,2022, 'Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data', Journal of neurology, neurosurgery, and psychiatry, 93, pp. 6 - 13, http://dx.doi.org/10.1136/jnnp-2021-327195
,2022, 'J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data', International Journal of Stroke, 17, pp. 1129 - 1136, http://dx.doi.org/10.1177/17474930211064076
,2022, 'Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress', International Journal of Stroke, 17, pp. 1156 - 1162, http://dx.doi.org/10.1177/17474930211068671
,2022, 'Cumulative Systolic Blood Pressure Load and Risk of Cardiovascular Outcomes in Patients With Diabetes', Heart, Lung and Circulation, 31, pp. S62 - S62, http://dx.doi.org/10.1016/j.hlc.2022.06.045
,2022, 'Limited Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management: Insights From Two Randomised Clinical Trials', Heart, Lung and Circulation, 31, pp. S64 - S64, http://dx.doi.org/10.1016/j.hlc.2022.06.048
,2021, 'Glycemic excursions and subclinical cardiac damage in adults with type 2 diabetes: Results from the ADVANCE Trial', Diabetes Research and Clinical Practice, 182, pp. 109148, http://dx.doi.org/10.1016/j.diabres.2021.109148
,2021, 'History of lower-limb complications and risk of cancer death in people with type 2 diabetes', Cardiovascular Diabetology, 20, pp. 3, http://dx.doi.org/10.1186/s12933-020-01198-y
,2021, 'Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?', Journal of the American Heart Association, 10, pp. e022240, http://dx.doi.org/10.1161/JAHA.121.022240
,2021, 'PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke', Cerebrovascular Diseases, 50, pp. 617 - 621, http://dx.doi.org/10.1159/000518181
,2021, 'Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials', BMC Medical Research Methodology, 21, http://dx.doi.org/10.1186/s12874-021-01388-6
,2021, 'Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis', The Lancet, 398, pp. 1803 - 1810, http://dx.doi.org/10.1016/S0140-6736(21)01920-6
,2021, 'Impact of Model Choice When Studying the Relationship Between Blood Pressure Variability and Risk of Stroke Recurrence', Hypertension, 78, pp. 1520 - 1526, http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16807
,2021, 'The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials', Journal of Human Hypertension, 35, pp. 946 - 957, http://dx.doi.org/10.1038/s41371-021-00510-x
,2021, 'Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (Diabetologia, (2021), 64, 9, (2012-2025), 10.1007/s00125-021-05491-7)', Diabetologia, 64, pp. 2355 - 2356, http://dx.doi.org/10.1007/s00125-021-05544-x
,2021, 'Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis', The Lancet, 398, pp. 1053 - 1064, http://dx.doi.org/10.1016/S0140-6736(21)01921-8
,2021, 'Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial', The Lancet, 398, pp. 1043 - 1052, http://dx.doi.org/10.1016/S0140-6736(21)01922-X
,2021, 'Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial', Cerebrovascular Diseases, 50, pp. 560 - 566, http://dx.doi.org/10.1159/000516487
,2021, 'Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control', Diabetologia, 64, pp. 2012 - 2025, http://dx.doi.org/10.1007/s00125-021-05491-7
,2021, 'Smoking influences outcome in patients who had thrombolysed ischaemic stroke: The ENCHANTED study', Stroke and Vascular Neurology, 6, pp. 395 - 401, http://dx.doi.org/10.1136/svn-2020-000493
,2021, 'Regional Differences in Early BP Management After Acute Ischemic Stroke in the ENCHANTED International Randomized Controlled Trials', Frontiers in Neurology, 12, pp. 687862, http://dx.doi.org/10.3389/fneur.2021.687862
,2021, 'Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials', Journal of hypertension, 39, pp. 1689 - 1696, http://dx.doi.org/10.1097/HJH.0000000000002862
,2021, 'Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1775 - 1785, http://dx.doi.org/10.1111/dom.14391
,2021, 'Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis', PLoS Medicine, 18, pp. e1003599, http://dx.doi.org/10.1371/journal.pmed.1003599
,2021, 'The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1292 - 1300, http://dx.doi.org/10.1111/dom.14339
,2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351
,2021, 'Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis', The Lancet, 397, pp. 1625 - 1636, http://dx.doi.org/10.1016/S0140-6736(21)00590-0
,2021, 'Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis', The Lancet Oncology, 22, pp. 558 - 570, http://dx.doi.org/10.1016/S1470-2045(21)00033-4
,2021, 'Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline', Kidney International, 99, pp. 926 - 939, http://dx.doi.org/10.1016/j.kint.2020.09.030
,2021, 'Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial', Neurology, 96, pp. E1512 - E1526, http://dx.doi.org/10.1212/WNL.0000000000011598
,2021, 'Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes', Canadian Journal of Diabetes, 45, pp. 129 - 136, http://dx.doi.org/10.1016/j.jcjd.2020.06.010
,2021, 'Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial', European Journal of Neurology, 28, pp. 783 - 793, http://dx.doi.org/10.1111/ene.14598
,2021, 'Low Dose versus Standard Dose Alteplase in Acute Lacunar Ischemic Stroke.', STROKE, 52, http://dx.doi.org/10.1161/str.52.suppl_1.MP3
,2021, 'Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.', Diabetes Care, http://dx.doi.org/10.2337/dc21er04b
,2021, 'Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study', Stroke, 52, pp. 722 - 725, http://dx.doi.org/10.1161/STROKEAHA.120.030435
,2021, 'Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications', Diabetes Care, 44, pp. 390 - 398, http://dx.doi.org/10.2337/dc20-0567
,2021, 'Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke inthe ENCHANTEDtrial', Journal of Hypertension, 39, pp. 280 - 285, http://dx.doi.org/10.1097/HJH.0000000000002640
,2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295, http://dx.doi.org/10.1016/j.ekir.2020.10.039
,2021, 'Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses', Diabetologia, 64, pp. 275 - 287, http://dx.doi.org/10.1007/s00125-020-05319-w
,2021, 'Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm', International Journal of Stroke, 16, pp. 222 - 228, http://dx.doi.org/10.1177/1747493019897858
,, 2021, 'Erratum to: Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications (Diabetes Care 2021; 44: 390–398)', Diabetes Care, 44, pp. 1072, http://dx.doi.org/10.2337/dc21-er04b
2021, 'Novel lipid species for detecting and predicting atrial fibrillation in patients with type 2 diabetes', Diabetes, 70, pp. 255 - 261, http://dx.doi.org/10.2337/db20-0653
,2021, 'The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: Results from the ADVANCE trial', Diabetes Care, 44, pp. 1622 - 1629, http://dx.doi.org/10.2337/dc20-2664
,2021, 'Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol', American Heart Journal, 231, pp. 56 - 67, http://dx.doi.org/10.1016/j.ahj.2020.09.017
,2021, 'Impact of model choice when studying the relationship between blood pressure variability and risk of stroke', Revue d'Épidémiologie et de Santé Publique, 69, pp. S57 - S57, http://dx.doi.org/10.1016/j.respe.2021.04.095
,